drugset / Trial / NCT03436160
Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds
Phase 0
Completed
18 enrolled
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR) · collab
RandomizedParallel-groupOpen-labelDiagnostic
Summary
Open-label, randomized, microdose study
Timeline
- Start
- 2018-08-10
- Primary completion
- 2018-11-03
- Completion
- 2018-11-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WR826647 | Small molecule | 100 ug | Intravenous |
| Subject | WR909388 | Small molecule | 100 ug | Intravenous |
| Subject | WR909390 | Small molecule | 100 ug | Intravenous |